|

Parkinson's Disease Clinical Trials in Long Beach, CA

18 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseasePhase 17 mi
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 27 mi
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—14 mi
A Study of Buntanetap in Participants With PDPhase 2/314 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 317 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 320 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—20 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 220 mi
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseasePhase 1/220 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—20 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/320 mi
Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst StimulationN/A20 mi
Parkinson's Foundation PD GENEration Genetic Registry—20 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—22 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 222 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 423 mi
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's DiseaseN/A24 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 430 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.